Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury

Brain Research

Volumn 1104, Issue 1, 2006, Pages 183-189

  Toczyłowska, Beata ^a,b   Chalimoniuk, Małgorzata ^c   Wodowska, Magdalena ^d   Mayzner Zawadzk, Ewa ^d  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Amino acid; Brain trauma; Cerebrospinal fluid; Nitric oxide; Proton NMR spectroscopy

Indexed keywords

AMINO ACID; ARGININE; CARBOXYLIC ACID; CITRULLINE; LACTIC ACID; NITRIC OXIDE; PYRUVIC ACID;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; INTENSIVE CARE UNIT; LUMBAR PUNCTURE; MONITORING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SUBARACHNOID SPACE; TRAUMATIC BRAIN INJURY;

ADULT; AMINO ACIDS; BRAIN INJURIES; FEMALE; GLASGOW COMA SCALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NITRIC OXIDE; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 33746615101     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.057     Document Type: Article

References (32)

1. Aquilani R., Iadarola P., Boschi F., Pistarini C., Arcidiaco P., and Contardi A. Reduced plasma levels of tyrosine, precursor of brain catecholamines, and of essential amino acids in patients with severe traumatic brain injury after rehabilitation. Arch. Phys. Med. Rehabil. 84 (2003) 1258-1265
2. Barker P.B., and Phil D. Fundamentals of Clinical MRS. ISMRM-ESMRMB Joint Annual Meeting, Glasgow, Scotland, UK (2001) 168-176
3. Baumgartner W.A., Redmond M., Brock M., Tseng E., Blue M.E., and Troncoso J.C. Pathophysiology of cerebral injury and future management. J. Card Surg. 12 (1997) 300-310
4. Brown J.I., Baker A.J., Konasiewicz S.J., and Moulton R.J. Clinical significance of CSF glutamate concentrations following severe traumatic brain injury in humans. J. Neurotrauma 15 (1998) 253-263
5. Calzada J.I., Jones B.E., Netland P.A., and Johnson D.A. Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers. Neurochem. Res. 27 (2002) 79-88
6. Davie C.A., Hawkins C.P., Barker G.J., Brennan A., Tofts P.S., and Miller D.H. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117 Pt. 1 (1994) 49-58
7. Dawson T.M., Dawson V.L., and Snyder S.H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32 (1992) 297-311
8. Kalloniatis M. Amino acids in neurotransmission and disease. J. Am. Optom. Assoc. 66 (1995) 750-757
9. Li W., Xia J.M., and Sun G.Y. Cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DINCT): response to genistein and pyrrolidine dithiocarbomate. J. Interferon Cytokine Res. 19 (1999) 121-127
10. Lynch D.R., and Dawson T.M. Secondary mechanisms in neuronal trauma. Curr. Opin. Neurol. 7 (1994) 510-516
11. Marion D.W., Puccio A., Wisniewski S.R., Kochanek P., Dixon C.E., Bullian L., and Carlier P. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit. Care Med. 30 (2002) 2619-2625
12. Marshall L.F., Toole B.M., and Bowers S.A. The National Traumatic Coma Data Bank. Part 2: Patients who talk and deteriorate: implications for treatment. J. Neurosurg. 59 (1983) 285-288
13. Martin R.L. Experimental neuronal protection in cerebral ischaemia. Part II: Potential neuroprotective drugs. J. Clin. Neurosci. 4 (1997) 290-310
14. Mascalchi M., Tosetti M., Plasmati R., Bianchi M.C., Tessa C., Salvi F., Frontali M., Valzania F., Bartolozzi C., and Tassinari C.A. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1. Ann. Neurol. 43 (1998) 244-252
15. McAdoo D.J., Hughes M.G., Nie L., Shah B., Clifton C., and Fullwood S. The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage → glutamate release → damage → glutamate release → etc. Brain Res. 1038 (2005) 92-99
16. Palmer A.M., Marion D.W., Botscheller M.L., Bowen D.M., and DeKosky S.T. Increased transmitter amino acid concentration in human ventricular CSF after brain trauma. NeuroReport 6 (1994) 153-156
17. Rosenberg G.A., Kyner W.T., and Estrada E. Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions. Am. J. Physiol. 238 (1980) F42-F49
18. Ruppel R.A., Kochanek P.M., Adelson P.D., Rose M.E., Wisniewski S.R., Bell M.J., Clark R.S., Marion D.W., and Graham S.H. Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. J. Pediatr. 138 (2001) 18-25
19. Sadasivudu B., and Rao T.I. Studies on functional and metabolic role of urea cycle intermediates in brain. J. Neurochem. 27 (1976) 785-794
20. Shimada N., Graf R., Rosner G., and Heiss W.-D. Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter and cerebrospinal fluid. J. Neurochem. 60 (1993) 66-71
21. Shuaib A., Ijaz S., Miyashita H., Mainprize T., and Kanthan R. Progressive decrease in extracellular GABA concentrations in the post-ischemic period in the striatum: a microdialysis study. Brain Res. 666 (1994) 99-103
22. Silberstein M., Lane D., Dodd S., and Opeskin K. Identification of by-product of nitric oxide synthase activity in human acute brain injury with in vivo proton magnetic resonance spectroscopy. Am. J. Neuroradiol. (2002) 389-392
23. Stover J.F., and Unterberg A.W. Increased cerebrospinal fluid glutamate and taurine concentrations are associated with traumatic brain edema formation in rats. Brain Res. 875 (2000) 51-55
24. Takahashi T. Monoamines, monoamine metabolites, neuron specific enolase and myelin basic protein concentrations in cerebrospinal fluid of resuscitated patients. Nihon Shinkei Seishin Yakurigaku Zasshi 17 (1997) 7-16
25. Tedeschi G., Litvan I., Bonavita S., Bertolino A., Lundbom N., Patronas N.J., and Hallett M. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 120 Pt. 9 (1997) 1541-1552
26. Vannucci R.C., Brucklacher R.M., and Vannucci S.J. CSF glutamate during hypoxia-ischemia in the immature rat. Brain Res. Dev. Brain Res. 118 (1999) 147-151
27. Wagner A.K., Bayir H., Ren D., Puccio A., Zafonte R.D., and Kochanek P. Relationship between cerebrospinal fluid marker of exicitotoxicity, ischemia, and oxidative damage after severe TBI: the input of gender, age, and hypothermia. J. Neurotrauma 21 (2004) 125-136
28. Wagner A.K., Chen X., Kline A.E., Li Y., R.D. Z., and Dixon C.E. Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp. Neurol. 195 (2005) 475-483
29. Wevers R.A., Engelke U.F., Wendel U., de Jong J.G., Gabreels F.J., and Heerschap A. Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin. Chem. 41 (1995) 744-751
30. Williams S. Biomedical in vitro spectroscopy. ISMRM-ESMRMB Joint Annual Meeting, Glasgow, Scotland, UK (2001) 329-336
31. Yang Y., Li Q., Miyashita H., Yang T., and Shuaib A. Different dynamic patterns of extracellular glutamate release in rat hippocampus after permanent or 30-min transient cerebral ischemia and histological correlation. Neuropathology 21 (2001) 181-187
32. Zhong C., Zhao X., Sarva J., Kozikowski A., Neale J.H., and Lyeth B.G. NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats. J. Neurotrauma 22 (2005) 266-276